Cantor Fitzgerald Begins Coverage on Cabaletta Bio (NASDAQ:CABA)

Cantor Fitzgerald initiated coverage on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. The firm issued an overweight rating and a $40.00 price target on the stock. Cantor Fitzgerald also issued estimates for Cabaletta Bio’s FY2023 earnings at ($1.70) EPS and FY2024 earnings at ($1.97) EPS. […]

Leave a Reply

Your email address will not be published.

Previous post Raymond James Downgrades Black Stone Minerals (NYSE:BSM) to Market Perform
Next post Colombia September 2023: Mazda (+31.3%), Nissan (+30.6%) challenge market down -34.7%